Added sugars may increase blood pressure more than high salt consumption
the ONA take:
Added sugars may increase risk of hypertension and cardiovascular disease more than salt, according to new research. Cardiovascular disease is the number one cause of premature mortality, and hypertension is its most important risk factor.
Current preventive measures for hypertension involve restricting dietary sodium, particularly by avoiding processed foods.
However, researchers from the Department of Preventive Cardiology at Saint Luke’s Mid America Heart Institute in Kansas City, Missouri, note that processed foods also have high levels of refined carbohydrates, namely various sugars and simple starches that increase blood glucose levels through digestion.
The most common sugars are sucrose, or table sugar, and high-fructose corn syrup (HFCS), the most frequently used sweetener in processed foods, in particular fruit drinks and sodas. Consuming one 24-ounce soft drink can cause an average maximum increase in blood pressure of 15/9 mm Hg and heart rate of 9 bpm.
The study findings indicate that even moderate doses of added sugars for short durations may cause harm. Consuming naturally occurring sugars, such as whole fruits, however, is not harmful and may even be beneficial.
Added sugars may increase risk of hypertension and cardiovascular disease more than salt.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|